An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer -. J. Can. Res. Updates. 2013;2(1): 21-25. doi:10.6000/1929-2279.2013.02.01.4